Merck & Co., Inc. (NYSE:MRK) August 12, 2015 0

Stock Price
View Comparative Chart →
Full Screen
1D
Chart
Select Tool
  • O:
  • H:
  • V:
  • C:
  • L:
savecancel
(right-click to delete)
--
MRK-US
Implied Price
UNDERVALUED
52.49 63.64
A Price as of Close Aug 11 57.76 USD
B CapitalCube Median Implied Price 62.09 USD * CapitalCube Price is over trading range * CapitalCube Price is below trading range
CapitalCube Estimate Range 60.54 - 63.64 USD NA
52 Week Range 52.49 - 63.62 USD
Earnings Momentum Score
 0  100
A Earnings Score (MRK) 33.46
B Earnings Score(Peer Median) 40.68
Latest Filing date June 30, 2015
Fundamental Score
 0  100
A Fundamental Score (MRK) 56
B Fundamental Score(Peer Median) 56
Dividend Score
 0  100
A Dividend Quality Score (MRK) 67
B Dividend Quality Score (Peer Median) 67
Dividend Yield
1.64 4.22
A Dividend Yield (MRK) 3.10
B Dividend Yield (Peer Median) 2.37
Sentiment
MRK
50t
15m
1h

Time your trades.

Real-time sentiment based on short, mid, and long term trends.

Analysis
Unlock The Complete Analysis →

Fundamental Analysis

Capital Investment Strategy unlock attributes

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Aperiam doloribus eius excepturi exercitationem, facere ipsa iure laudantium nulla quaerat qui sunt tempora, unde voluptate

Earnings Leverage unlock attributes

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Aperiam doloribus eius excepturi exercitationem, facere ipsa iure laudantium nulla quaerat qui sunt tempora, unde voluptate

Leverage & Liquidity unlock attributes

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Aperiam doloribus eius excepturi exercitationem, facere ipsa iure laudantium nulla quaerat qui sunt tempora, unde voluptate

Relative Valuation unlock attributes

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Aperiam doloribus eius excepturi exercitationem, facere ipsa iure laudantium nulla quaerat qui sunt tempora, unde voluptate

Valuation Drivers unlock attributes

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Aperiam doloribus eius excepturi exercitationem, facere ipsa iure laudantium nulla quaerat qui sunt tempora, unde voluptate

Drivers of Margin unlock attributes

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Aperiam doloribus eius excepturi exercitationem, facere ipsa iure laudantium nulla quaerat qui sunt tempora, unde voluptate

Growth Expectations unlock attributes

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Aperiam doloribus eius excepturi exercitationem, facere ipsa iure laudantium nulla quaerat qui sunt tempora, unde voluptate

Operations Diagnostic unlock attributes

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Aperiam doloribus eius excepturi exercitationem, facere ipsa iure laudantium nulla quaerat qui sunt tempora, unde voluptate

Sustainability of Returns unlock attributes

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Aperiam doloribus eius excepturi exercitationem, facere ipsa iure laudantium nulla quaerat qui sunt tempora, unde voluptate

Likely Corporate Actions

Dividend Action unlock attributes

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Aperiam doloribus eius excepturi exercitationem, facere ipsa iure laudantium nulla quaerat qui sunt tempora, unde voluptate

Equity Action unlock attributes

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Aperiam doloribus eius excepturi exercitationem, facere ipsa iure laudantium nulla quaerat qui sunt tempora, unde voluptate

M&A Action unlock attributes

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Aperiam doloribus eius excepturi exercitationem, facere ipsa iure laudantium nulla quaerat qui sunt tempora, unde voluptate

Dividend Quality

Dividend Coverage unlock attributes

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Aperiam doloribus eius excepturi exercitationem, facere ipsa iure laudantium nulla quaerat qui sunt tempora, unde voluptate

Dividend Quality unlock attributes

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Aperiam doloribus eius excepturi exercitationem, facere ipsa iure laudantium nulla quaerat qui sunt tempora, unde voluptate

Dividend Quality Trend unlock attributes

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Aperiam doloribus eius excepturi exercitationem, facere ipsa iure laudantium nulla quaerat qui sunt tempora, unde voluptate

Accounting Red Flags

Accounting Quality unlock attributes

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Aperiam doloribus eius excepturi exercitationem, facere ipsa iure laudantium nulla quaerat qui sunt tempora, unde voluptate

Management of Reserves unlock attributes

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Aperiam doloribus eius excepturi exercitationem, facere ipsa iure laudantium nulla quaerat qui sunt tempora, unde voluptate

Material Categories unlock attributes

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Aperiam doloribus eius excepturi exercitationem, facere ipsa iure laudantium nulla quaerat qui sunt tempora, unde voluptate
Price History

Peers

FA Score

DQ Score

close

52 week range

57.76

52.49

63.62

USD

35.12

27.51

36.46

USD

99.01

95.10

109.49

USD

62.66

47.55

70.54

USD

83.54

60.46

90.18

USD

54.39

43.57

57.42

USD

44.78

41.19

49.24

USD

281.72

257.20

320.50

USD

102.10

84.17

106.84

USD

50.39

39.28

51.74

USD

Company Profile

Merck & Co., Inc. provides various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products worldwide. It is a global research-driven pharmaceutical company that discovers, develops, manufactures and markets vaccines and medicines to address unmet medical needs. The company operates through the following segments: Pharmaceutical, Animal Health and Alliances. The Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the company or through joint ventures. Its human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The company sells these products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers, such as health maintenance organizations, pharmacy benefit managers and other institutions. Its vaccine products consist of preventive pediatric, adolescent and adult vaccines, primarily administered at physician offices. The company sells these vaccines primarily to physicians, wholesalers, physician distributors and government entities. The Animal Health segment discovers, develops, manufactures and markets animal health products, including vaccines, which it sells to veterinarians, distributors and animal producers. The Alliances segment includes revenue from the company relationship with AstraZeneca LP. The company was founded in 1851 and is headquartered in Kenilworth, NJ.

Closing Stock Price

USD 57.76

As of Date

August 11, 2015

One Year Performance

1.94%

One Month Performance

-0.33%

Industry Group

Pharmaceuticals: Major

52 wk. Range

USD 52.49 - USD 63.62

Market Cap (Millions)

USD 162,688.84

Total Shares Outstanding

2823.955757
Latest Filing Dates

Annual

December 31, 2014

Semi Annual

N/A

Quarterly

June 30, 2015

Next Release Date

October 26, 2015

Filing Currency

USD

Listed Exchange

NYSE
Peers


Latest Tweets via StockTwits
MRK
Please login to stocktwits
Post your response
share chart (wait for to display dialog to show)
Message must be no longer than 140 characters.
21
share page
SwingTradeBot
1h
Scan results - Expansion Pivot Buy Setup today: $POM $COMM $APC $NVDQ $KR $CMP $EXC $SAFM $MSM $MRK ... http://stks.co/c2OIU
Aug 12 10:9 PM
Conference Call Transcripts
5h
PRING TURNER CAPITAL GROUP INC appears to have added to its $MRK position in the most recent quarter http://stks.co/c2OBj
Aug 12 6:1 PM
J.C. Parets
8h
NEW POST: Is Healthcare Due For A Collapse? http://stks.co/p2gCs $XLV $JNJ $GILD $MRK $PFE $SPY
Aug 12 3:30 PM
3
Jason
8h
Dow Components on Active Strike- $GS $MRK $WMT http://stks.co/d2O2O
Aug 12 3:14 PM
Jason
9h
Bubbly Stocks in Focal Point- $BRK-B $USB $MRK http://stks.co/b2Nyl
Aug 12 2:19 PM
DailyStockPlays.com
1d
End Of Day Scan: MACD Bearish Crossovers $AKAM $DGX $VSAT $MRK $CVGW $LBTYA $QSR $PBJ $SKYY $EXPR www.DailyStockPlays.com
Aug 11 10:49 PM
Warren of Wall St
1d
Aug 11 8:34 PM
Chris DeMuth Jr
1d
Aug 11 3:53 PM
WSNewsPublishers
1d
Active Stocks in Focus: http://stks.co/r2fp1 $FCX $ZNGA $MRK
Aug 11 3:39 PM
WSNewsPublishers
1d
Active Stocks in Focus: http://stks.co/a2Ne8 $FCX $ZNGA $MRK
Aug 11 3:32 PM
biotech15
1d
5 PEOPLE ARRESTED IN SCHEME TO HACK COMPANY PRESS RELEASES FOR INSIDER TRADING, IN U.S. CUSTODY - FBI $SGMO $MRK $AZN http://stks.co/i2wy6
Aug 11 12:47 PM
2 1
Conference Call Transcripts
2d
BRANDES INVESTMENT PARTNERS, LP appears to have added to its $MRK position in the most recent quarter http://stks.co/f2wU7
Aug 10 7:5 PM
Anacott Steel
2d
$GILD incredible short interest drop in a month.No one cares about $MRK pricing pressure.Huge holding of hedge funds. Margin calls? #biotech
Aug 10 6:51 PM
Tom P
2d
$MRK Going to be in talks with ARYC
Aug 10 5:51 PM
Vinny
2d
$MRK In the end these companies will be the biggest killers of the economy, as people give up their entire 401k, IRA, to pay for a drug
Aug 10 4:0 PM
1
Vinny
2d
$MRK Living off the blood of others
Aug 10 3:52 PM
Vinny
2d
$MRK Rot in hell Merck, and I hope all you people that buy into these blood thirsty drug companies rot in hell as well, like vampires
Aug 10 3:51 PM
1
Quantcha
2d
Price Target Alert: Trading the Zacks price target change for MERCK $MRK http://stks.co/b2N6t
Aug 10 3:10 PM
Bidness Etc
2d
Zynerba Stock Boost On New Board Appointments - http://stks.co/i2wWh $ZYNE $MRK
Aug 10 2:16 PM
CHItraders
2d
$MRK and $IMDS to Collaborate on Combination Trials of 2 Immune Design Immunotherapies. http://stks.co/p2f8D
Aug 10 12:28 PM
1
CaptainSolo
4d
$GILD A patient in Japan pays $335 for 12 weeks of Sovaldi? Docs not going to choose Viekira there. http://stks.co/d2Ms8 $ABBV $MRK $BMY
Aug 9 7:59 AM
1
Jay
4d
$SYN $MRK also in the mix for Trimesta IMO
Aug 8 5:23 PM
1
CaptainSolo
4d
$GILD Is $335 for a 12 week treatment of Sovaldi a high price to pay? Japanese don't think so http://stks.co/p2en0 $ABBV $MRK $BMY $PFE
Aug 8 11:4 AM
DL Haze
5d
@harryzimm2013 LOL I hope $AAPL $WMB $KMI $NOC $T $CELG $GILD $MRK
Aug 8 1:3 AM
16
WSNewsPublishers
5d
Pre-Market Stocks Roundup: http://stks.co/c2MXK $MRK $SU $CNQ $PAAS
Aug 7 4:11 PM
Sweet Platform
5d
MRK Top news - Aug 7th, 2015 $MRK goo.gl/KCT7rZ
Aug 7 2:58 PM
1
CaptainSolo
5d
$GILD Is $335 for a 12 week treatment of Sovaldi a high price to pay? Japanese don't think so http://stks.co/a2MPW $ABBV $MRK $BMY $PFE
Aug 7 12:41 PM
Yakob
6d
$IBB If trend breaks, $335 is next. Be careful . $CELG , $MRK , $BMY , $GILD , ...
Aug 7 2:56 AM
4 1
CaptainSolo
6d
$GILD Is $335 for a 12 week treatment of Sovaldi a high price to pay? http://stks.co/c2MGg $ABBV $MRK $BMY $PFE
Aug 6 11:51 PM
2
DailyStockPlays.com
6d
End Of Day Scan: Below Ichimoku Cloud $SPY $EWJ $MRK $JNJ $KEY $XLK $VIP $GERN $SSO $IVV www.DailyStockPlays.com Learn How We Trade
Aug 6 10:43 PM
Please Login to see your stream! No Twits! Your stream is empty No Twits for MRK!

Closing Stock Price

USD 57.76

As of Date

August 11, 2015

One Year Performance

1.94%

One Month Performance

-0.33%

Industry Group

Pharmaceuticals: Major

52 wk. Range

USD 52.49 - USD 63.62

Market Cap (Millions)

USD 162,688.838

Total Shares Outstanding (Millions)

2,823.96
Latest Filing Dates

Annual

December 31, 2014

Semi Annual

N/A

Quarterly

June 30, 2015

Next Release Date

October 26, 2015

Filing Currency

USD

Listed Exchange

NYSE
Register
to customize peers
Peer analysis →